| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT05827081 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Trial sites expanded: 207 -> 215 locations |
| 2026-05-23 | NCT03860987 Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using… |
Trial completed |
| 2026-05-23 | NCT03860987 Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using… |
date change Primary completion moved earlier: 2026-07-31 -> 2026-05-11 |
| 2026-05-23 | NCT03860987 Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using… |
date change Completion moved earlier: 2028-08-01 -> 2026-05-18 |
| 2026-05-23 | NCT07287098 A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… |
Trial sites expanded: 42 -> 60 locations |
| 2026-05-16 | NCT04423211 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… |
Trial sites expanded: 303 -> 342 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06523530 | Effect of a GnRH Analog on Hepatic Steatosis | Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting |
| NCT05161195 | Roll-over Study to Allow Continued Access to Ribociclib | Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 3 | |||
| NCT04423211 | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… | Biochemically Recurrent Prostate Carcinoma | Recruiting |
| NCT05827081 | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Early Breast Cancer | Recruiting |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT04513717 | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT05050084 | Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT04484818 | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy… | Prostate Carcinoma | Active, Not Recruiting |
| NCT02115282 | Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone… | Anatomic Stage III Breast Cancer AJCC v8 | Active, Not Recruiting |
| Phase 2 | |||
| NCT03942653 | Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen… | Salivary Gland Carcinoma | Recruiting |
| NCT04734730 | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07158021 | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT06348134 | Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+… | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Recruiting |
| NCT06378866 | Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway… | Recurrent Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT06953882 | Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative… | HER2 Negative Breast Cancer | Recruiting |
| NCT05582499 | Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… | Breast Neoplasm | Recruiting |
| NCT01786265 | Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT07460752 | Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function… | Anatomic Stage I Breast Cancer AJCC v8 | Not Yet Recruiting |
| NCT03361735 | Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT00544830 | Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With… | PSA Level Greater Than Two | Active, Not Recruiting |
| NCT07287098 | A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… | Breast Neoplasms | Not Yet Recruiting |
| Not specified | |||
| NCT02346253 | High-Dose Brachytherapy in Treating Patients With Prostate Cancer | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT07552480 | Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell… | Allogeneic Haematopoietic Stem Cell Transplantation | Not Yet Recruiting |
| NCT07552493 | Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic… | Ovarian Insufficiency | Not Yet Recruiting |